{"id":"https://openalex.org/W4404064053","doi":"https://doi.org/10.1136/jitc-2024-sitc2024.1288","title":"1288 Determination of first in human dose of the T cell-redirecting bispecific antibody CTIM-76 targeting Claudin 6","display_name":"1288 Determination of first in human dose of the T cell-redirecting bispecific antibody CTIM-76 targeting Claudin 6","publication_year":2024,"publication_date":"2024-11-01","ids":{"openalex":"https://openalex.org/W4404064053","doi":"https://doi.org/10.1136/jitc-2024-sitc2024.1288"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2024-sitc2024.1288","doi":"https://doi.org/10.1136/jitc-2024-sitc2024.1288","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2024-sitc2024.1288","pdf_url":null,"source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1136/jitc-2024-sitc2024.1288","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006927893","display_name":"Kelly A. Byrnes-Blake","orcid":"https://orcid.org/0000-0001-7588-7521","observed_orcids":["https://orcid.org/0000-0001-7588-7521"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kelly Byrnes-Blake","raw_affiliation_strings":["Context Therapeutics, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Context Therapeutics, Philadelphia, PA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069147730","display_name":"Ed Calamai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ed Calamai","raw_affiliation_strings":["PMC Associates, Kingston, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PMC Associates, Kingston, NY, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035662028","display_name":"Stanley Roberts","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stanley Roberts","raw_affiliation_strings":["SAR Safety Assessment, Northbrook, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SAR Safety Assessment, Northbrook, IL, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084740629","display_name":"Eric A. Butz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eric Butz","raw_affiliation_strings":["Cascadia Drug Development Group, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cascadia Drug Development Group, Seattle, WA, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A1447","last_page":"A1447"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.4675000011920929,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.4675000011920929,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.4332999885082245,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.014600000344216824,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/claudin-6","display_name":"CLDN6","score":0.8859999775886536},{"id":"https://openalex.org/keywords/no-observed-adverse-effect-level","display_name":"no-observed-adverse-effect level","score":0.9559999704360962},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8529999852180481},{"id":"https://openalex.org/keywords/safety-margin","display_name":"safety margin","score":0.5509999990463257},{"id":"https://openalex.org/keywords/cd3","display_name":"CD3","score":0.35600000619888306},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.574999988079071}],"concepts":[{"id":"https://openalex.org/C51872919","wikidata":"https://www.wikidata.org/wiki/Q420863","display_name":"Claudin","level":3,"score":0.5304291248321533},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.49533286690711975},{"id":"https://openalex.org/C3020495827","wikidata":"https://www.wikidata.org/wiki/Q426141","display_name":"Bispecific antibody","level":4,"score":0.4807288944721222},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3749236762523651},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.29343295097351074},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2770625054836273},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.26511406898498535},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19969990849494934},{"id":"https://openalex.org/C177779419","wikidata":"https://www.wikidata.org/wiki/Q1053832","display_name":"Tight junction","level":2,"score":0.1549677848815918},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.14307540655136108}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2024-sitc2024.1288","doi":"https://doi.org/10.1136/jitc-2024-sitc2024.1288","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2024-sitc2024.1288","pdf_url":null,"source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2024-sitc2024.1288","doi":"https://doi.org/10.1136/jitc-2024-sitc2024.1288","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2024-sitc2024.1288","pdf_url":null,"source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4409630553","https://openalex.org/W4388048303","https://openalex.org/W3015389972","https://openalex.org/W4402567471","https://openalex.org/W4285794284","https://openalex.org/W2469610249","https://openalex.org/W4407701012","https://openalex.org/W3005376643","https://openalex.org/W4379283649","https://openalex.org/W2162112601"],"abstract_inverted_index":{"Background":[0],"CTIM-76":[1,49],"is":[2,14,28,128,186],"a":[3,85,118,148,154,168,230],"Claudin":[4],"6":[5],"(CLDN6)":[6],"x":[7],"CD3":[8],"bispecific":[9],"T":[10],"cell-redirecting":[11],"antibody":[12],"that":[13],"in":[15,84,98,117,234],"phase":[16],"1":[17],"clinical":[18,264],"development.":[19],"The":[20,196,251],"minimal":[21],"anticipated":[22],"biological":[23],"effect":[24,58],"level":[25,59,185],"(MABEL)":[26],"approach":[27],"standard":[29],"for":[30,79],"determining":[31],"the":[32,45,52,72,93,101,132,144,173,177,189,193,215,259,262],"first-in-human":[33,46],"dose":[34,47,87,105,135,151,184,190,233,266],"potent":[35],"of":[36,48,64,88,124,136,158,214,217,240,253,255,261,267],"immune-activating":[37],"drugs.":[38],"Methods":[39],"Accordingly,":[40],"we":[41],"aimed":[42],"to":[43,70,172],"determine":[44],"using":[50],"both":[51],"MABEL":[53,80,194],"and":[54,75,82,156,161,200,206,224,242,247],"no":[55],"observed":[56],"adverse":[57],"(NOAEL)":[60],"approaches.":[61],"CTIM-76-induced":[62],"lysis":[63],"OV-90":[65,178],"tumor":[66],"cells":[67],"was":[68,107],"determined":[69],"be":[71],"most":[73],"sensitive":[74],"pharmacologically":[76,182],"relevant":[77],"measure":[78],"calculations":[81],"resulted":[83],"starting":[86,121,265],"22.5":[89,137,149,231,268],"mcg.":[90],"Results":[91],"In":[92],"4-week":[94],"GLP":[95],"toxicology":[96],"study":[97],"nonhuman":[99],"primates":[100],"highest":[102],"non-severely":[103],"toxic":[104],"(HNSTD)":[106],"0.2":[108,218],"mg/kg.":[109,126],"Based":[110,142],"on":[111,143,204,245],"ICH":[112],"S9":[113],"guidance,":[114],"this":[115],"results":[116],"maximum":[119],"recommended":[120],"dosage":[122],"(MRSD)":[123],"0.033":[125],"This":[127,180],"substantially":[129],"higher":[130],"than":[131],"proposed":[133,191,263],"FIH":[134],"mcg":[138,150,232,269],"(0.":[139],"32":[140],"mcg/kg).":[141],"predicted":[145],"human":[146],"PK,":[147],"would":[152,166,236],"give":[153],"Cmax":[155,169,199,246],"AUC":[157,201],"5.33":[159],"ng/mL":[160,223],"206":[162],"hr*ng/mL,":[163,227],"respectively,":[164],"which":[165],"provide":[167],"approximately":[170],"equivalent":[171],"EC50":[174],"value":[175],"from":[176],"assay.":[179],"minimally":[181],"active":[183],"consistent":[187],"with":[188],"by":[192],"approach.":[195],"mean":[197],"(SD)":[198],"values,":[202],"based":[203,244],"males":[205],"females":[207],"combined,":[208],"after":[209],"repeat":[210],"dosing":[211],"(Day":[212],"29)":[213],"HNSTD":[216],"mg/kg,":[219],"were":[220],"2460":[221],"(820)":[222],"80900":[225],"(37800)":[226],"respectively.":[228,249],"Therefore,":[229],"humans":[235],"have":[237],"safety":[238,260],"margins":[239],"462":[241],"393":[243],"AUC,":[248],"Conclusions":[250],"weight":[252],"evidence":[254],"these":[256],"data":[257],"supports":[258],"CTIM-76.":[270]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2024-11-06T00:00:00"}